Abelcet Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Funding
• Alerts
• Clinical Trials

Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)
Conditions:   Vulvovaginitis;   Yeast Infection;   Yeast Infection Vaginal;   Candidiasis, Vulvovaginal Interventions:   Drug: Oral Encochleated Amphotericin B (CAMB);   Drug: Fluconazole Sponsor:   Matinas BioPharma Nanotechnologies, Inc. Recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2016 Category: Research Source Type: clinical trials